Capecitabine induced acute coronary syndrome

No abstract is available for this paper.

• Publication year

  2009

• Venue

  BMJ Case Reports

• Publication date

  2009-04-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bcr.09.2008.0964PMID 21686536PMCID PMC3029866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Capecitabine-induced coronary vasospasm.

  2008cited by this paper
• Acute coronary syndrome induced by capecitabine therapy.

  2006cited by this paper
• Capecitabine-Induced Coronary Vasospasm

  2004cited by this paper
• Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil.

  2002cited by this paper
• The syndrome of 5‐fluorouracil cardiotoxicity. An elusive cardiopathy

  1993cited by this paper
• In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.

  1993cited by this paper
• Letter: Cardiotoxicity of 5-fluorouracil (NSC-19893)

  1975cited by this paper

• Vascular Toxicities of Cancer Therapies: 2025 Update.

  2025cites this paper
• Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study

  2021cites this paper
• 5-fluorouracil and cardiotoxicity: a review

  2018cites this paper
• Cardiac arrest and ventricular fibrillation in a young man treated with capecitabine: Case report and literature review.

  2016cites this paper
• Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer

  2016cites this paper
• A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity

  2014cites this paper